Allarity Therapeutics, Inc. Increase (Decrease) in Income Taxes Payable
Allarity Therapeutics, Inc. (ALLR) reported Increase (Decrease) in Income Taxes Payable of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-14
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2025 was $7.00K, a 53.33% decline from fiscal 2024.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2024 was $15.00K, a 16.67% decline from fiscal 2023.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2023 was $18.00K.
- Allarity Therapeutics, Inc. increase (decrease) in income taxes payable for fiscal 2022 was -$19.00K, a 337.50% decline from fiscal 2021.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $5.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $5.00K derived: sum of 3 quarters · filed 2026-08-14 | $7.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $5.00K derived: sum of 2 quarters · filed 2026-08-14 | $7.00K 10-Q · filed 2025-11-14 | $21.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $7.00K 10-Q · filed 2026-08-14 | $21.00K derived: sum of 3 quarters · filed 2026-08-14 | $24.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $2.00K 10-Q · filed 2026-05-15 | $16.00K derived: sum of 2 quarters · filed 2026-05-15 | $19.00K derived: sum of 3 quarters · filed 2026-05-15 | $33.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $17.00K derived: sum of 2 quarters · filed 2026-03-30 | $31.00K derived: sum of 3 quarters · filed 2026-03-30 | $15.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $17.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.00K 10-Q · filed 2025-11-14 | $32.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$2.00K 10-Q · filed 2025-08-15 | $29.00K derived: sum of 3 quarters · filed 2025-08-15 | $21.00K derived: sum of 4 quarters · filed 2025-08-15 |
| 2024-03-31 | -$16.00K 10-Q · filed 2025-05-09 | $15.00K derived: sum of 2 quarters · filed 2025-05-09 | $7.00K derived: sum of 3 quarters · filed 2025-05-09 | $7.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $23.00K derived: sum of 2 quarters · filed 2025-03-31 | $23.00K derived: sum of 3 quarters · filed 2025-03-31 | $18.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$8.00K derived: sum of 2 quarters · filed 2024-11-14 | -$13.00K 10-Q · filed 2024-11-14 | -$55.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$5.00K 10-Q · filed 2024-08-05 | -$47.00K derived: sum of 3 quarters · filed 2024-08-05 | $10.00K derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$5.00K 10-Q · filed 2024-05-14 | -$47.00K derived: sum of 2 quarters · filed 2024-05-14 | $10.00K derived: sum of 3 quarters · filed 2024-05-14 | -$17.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $15.00K derived: sum of 2 quarters · filed 2024-03-08 | -$12.00K derived: sum of 3 quarters · filed 2024-03-08 | -$19.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $30.00K derived: sum of 2 quarters · filed 2023-11-14 | $23.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$34.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$7.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $8.00K 10-K · filed 2023-03-13 | |||
| 2021-06-30 | -$1.00K 10-Q · filed 2022-10-07 | |||
| 2020-12-31 | $33.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |